Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Patients seen in a typical rheumatology practice are at higher risk of PAH secondary to their conditions. Rheumatologists should maintain a high index of suspicion for PAH in their patients with systemic sclerosis and other mixed connective tissue disorders. Emerging evidence suggests that two of the most prevalent CTDs, systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), should be regarded as separate diseases due to their different etiologies, prognoses, and therapeutic responses. This slide kit will present insights into the different pathophysiological processes and management of patients with SSc and SLE-PAH, as well as recommendations for routine screening, risk factors, diagnosis, management, and ongoing monitoring of patients in a rheumatology practice for PAH.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Research shows that patients with PAH benefit greatly from early diagnosis and treatment. However, patients often face delays of two years or longer from the onset of symptoms before a definitive diagnosis of PAH is reached. Designed for primary care providers and other non-specialists, this case-based slide kit will cover the basics of the diagnosis of PAH, including discussions of the most-common alternative/incorrect diagnoses received by patients and the importance of early referral.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. The Lecture Library offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/posttest and evaluation.

Continue to visit the Lecture Library series throughout 2022 to view updates from new publications and conference updates. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Activity Summary:
Pulmonary arterial hypertension (PAH) is a debilitating and progressive disease characterized by pulmonary artery vasoconstriction and vascular remodeling leading to elevation of pulmonary arterial pressures and pulmonary vascular resistance. Current PAH-specific therapies have significantly improved the outlook for patients by improving functional capacity, pulmonary hemodynamics and reducing hospitalization. PAH remains an incurable disease necessitating further research and treatment options. This webcast provides an update on novel advances in pharmacological therapy in PAH.

This activity will focus on several important aspects of PAH management including a discussion of clinical trial data on emerging therapeutics for the management of PAH; and a review of strategies to optimize outcomes for patients with PAH.

Activity Summary:
This accredited AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals on top of the most recent clinical findings in PAH.

The fourth edition will feature Dr. Dunbar Ivy, Dr. Marc Humbert and Dr. Ronald Oudiz discussing an Update on Pediatric PAH Care; Patient Perspectives in PAH and What’s New in Imaging in PAH​.

Activity Summary:
Recent progress in PAH is based on new strategies for combination therapy and on the escalation of treatments to improve the significant morbidity and mortality associated with this disease.

Through patient cases, Ronald Oudiz, MD and Sonja Bartolome, MD discuss the importance of monitoring patients to determine when and how to optimally alter their PAH therapy. Case 1 will discuss diagnosis, initial management, disease progression, and treatment escalation. Case 2 will discuss how to manage the complications and precautions in a patient through pregnancy, labor and delivery, and the immediate postpartum period.

Activity Summary:
Pulmonary hypertension due to interstitial lung disease (PH-ILD) is a debilitating condition that has been classified recently. It poses significant challenges for clinical practice in terms of diagnosis and treatment. Updates in the understanding and management of PH-ILD, are hence widely anticipated.

These educational Clinical Clips will highlight important advances in the medical management of patients with PH-ILD on data presented at the American College of Chest Physicians Annual Meeting 2021.

Activity Summary:
This accredited continuing education activity features a recorded discussion among three experts and is designed to keep healthcare professionals abreast of the most recent clinical findings in pulmonary arterial hypertension (PAH).

In this edition, Dr. Ronald Oudiz, Dr. Aaron Waxman and Dr. Marius Hoeper discuss past and future challenges of the World Symposium on Pulmonary Hypertension (WSPH), cardiopulmonary exercise testing in PH and the unmet clinical needs in systemic sclerosis-associated PAH (SSc-PAH).

Activity Summary:
Improvements in the care of pulmonary arterial hypertension (PAH) patients depends on improving clinician awareness of the latest research into new diagnostic techniques, medications, and monitoring.

In this video, Jean Elwing, MD and David Badesch, MD discuss topics on diagnosis, differential diagnosis, right heart catheterization, risk assessment, treatment and patient perspectives in PAH.

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals abreast the most recent clinical findings in PAH.

The second edition will feature Dr. Ronald Oudiz, Dr. Nicholas Hill and Dr. Richard Channick discussing congress highlights from the International Society for Heart and Lung Transplantation and American Thoracic Society 2021, intensive care management of the PAH patient with COVID-19 and recent updates to the medical management of patients with CTEPH.

Activity Summary:
Improvements in the care of PAH patients depends on improving clinician awareness of the latest research into new diagnostic techniques, medications, and monitoring.

In this video, Dr. Robert Schilz and Dr. Victor Tapson discuss cutting-edge research in PAH to keep busy clinicians abreast of the current clinical data.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee. Talking PAH offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/post-test and evaluation.

Continue to visit this page throughout 2021 to register for an interactive opportunity with a PAH expert through one of our live webcasts. If you are unable to make the live webcast, you will be able to access the archived video here for credit.

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals on top of the most recent clinical findings in PAH.

The first edition will feature Dr. Ronald Oudiz, Dr. Murali Chakinala and Dr. Harrison Farber discussing updates on COVID-19 & PAH and recent treatment strategies of PAH and emerging research for 2021.

Activity Summary:
Conversations in PAH are accredited, on-demand video presentations that feature PAH experts discussing hot topics, recent clinical updates, conference updates and treatment options for managing patients with PAH. This activity is designed to keep healthcare professionals on top of the most recent clinical findings in PAH. A new video series will be released every quarter throughout 2021.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Acute right ventricular failure can be a devastating complication of severe PAH. Because of the difference between the left and right sides of the heart, tools and techniques dealing with left-heart failure often do not apply in the setting of the right heart or may even be counter-productive. Intensive case management of RV failure in this setting is extremely complex. This lecture provides top-line expert consensus on the management of acute RV failure.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

CTEPH is defined as PH in the presence of an organized thrombus within the pulmonary vascular bed that persists at least 3 months after the onset of anticoagulant therapy. The most commonly reported symptoms of CTEPH include exercise intolerance, fatigue, and dyspnea. Symptoms experienced by CTEPH patients are non-specific and often similar to those of other more common diseases, so CTEPH is under diagnosed and often misdiagnosed as another disease. CTEPH is potentially curable only with pulmonary endarterectomy (PEA) surgery, which is the treatment choice for patients who are surgical candidates. For patients who are not surgical candidates or who have persistent/recurrent CTEPH after PEA surgery, there is an approved medical therapy or percutaneous balloon pulmonary angioplasty (BPA). This slide kit covers diagnosis and emerging treatment strategies including sequencing and combination therapy.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Patients seen in a typical rheumatology practice are at higher risk of PAH secondary to their conditions. Rheumatologists should maintain a high index of suspicion for PAH in their patients with systemic sclerosis and other mixed connective tissue disorders. This lecture will present recommendations for routine screening of patients in a rheumatology practice for PAH as well as the basics of diagnosis and management of PAH.

Activity Summary:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease. Slides are developed and updated throughout the year by leading pulmonology expert physicians. Continue to visit the Lecture Library series throughout 2021 to view updates from new publications and conference updates. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

This activity is comprised of two clinical case scenarios to illustrate best-practice recommendations for diagnosis and further treatment and management of patients presenting with PH-ILD. The slides will provide guidance on safely and effectively integrating recent updates and evidence in PH-ILD into clinical practice.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Research shows that patients with PAH benefit greatly from early diagnosis and appropriate treatment. However, many patients face definitive diagnostic delays of two or more years. This activity is designed for primary care providers and other non-specialists, and incorporates case-based topics on diagnosis, differential diagnosis, right heart catheterization, risk assessment, treatment and patient perspectives.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease. Slides are developed and updated throughout the year by leading pulmonology expert physicians. Continue to visit the Lecture Library series throughout 2021 to view updates from new publications and conference updates. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

This activity is designed to provide an overview of the diagnosis, treatment, and management of patients presenting with PH-ILD. Latest evidence from completed and ongoing clinical trials will be presented to identify therapeutic approaches useful in reducing the symptom burden of afflicted patients. Current treatment paradigms, their limitations, and new developments in PH-ILD will also be discussed.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease. Slides are developed and updated throughout the year by leading PH-ILD expert physicians. The Lecture Library offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/posttest and evaluation.

Continue to visit the Lecture Library series throughout 2021 to view updates from new publications and conference updates. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Outpatient management of PAH requires unique and practical considerations, especially for those who require implantable pumps. Further management decisions regarding chronic anti-coagulation therapy, exercise recommendations, travel considerations, medication adherence, respite, and psychosocial issues must also be addressed. This slide kit is designed for the multi-disciplinary medical team to address the practical challenges of managing PAH.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and updated throughout the year by leading PAH expert physicians. The Lecture Library offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/posttest and evaluation.

Continue to visit the Lecture Library series throughout 2021 to view updates from new publications and conference updates. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Activity Summary:

This certified CME/CNE activity features a recorded discussion among three lung cancer experts that reviews the latest options for the management of early stage lung cancer.

This activity will feature Dr. Jack West, Dr. Mark Socinski and Dr. Jamie Chaft discussing the standard of care for early stage lung cancer and recent data on the early use of immunotherapy for adjuvant or neoadjuvant use in early lung cancer. The discussion will be supplemented by slides based on the discussion which are available for download.

Activity Summary:
The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary arterial hypertension (PAH), altering routine standard of care practice. It is critical to balance the ongoing care and evaluation of PAH with the potential "exposure risk" to COVID-19.

In this presentation, Ronald Oudiz, MD and Murali Chakinala, MD, highlight the latest clinical updates on COVID-19 as well as current guidelines, protocols and resources to support people with PAH.

Activity Summary:
Recent progress in PAH is based on new strategies for combination therapy and on the escalation of treatments to improve the significant morbidity and mortality associated with this disease. This module is designed as a case-based discussion on the importance of monitoring patients to determine when and how to optimally alter their PAH therapy.

In case 1, Ronald Oudiz, MD discusses diagnosis, initial management, disease progression, and treatment escalation. In case 2, Sonja Bartolme, MD discusses how to manage the complications and precautions in a patient through pregnancy, labor and delivery, and the immediate postpartum period.

Activity Summary:
Advanced Topics in PAH is designed to delve more deeply into advanced topics related to the management of patients with PAH.

This educational lecture, presented by Dr. Sonja Bartolome, discusses cardiopulmonary rehabilitation/exercise training for patients with PAH; pre-and-post capillary PH, including issues related to treatment decision-making; and best practices for performing the right-heart catheterization in clinical practice for patients suspected of having PAH, or who are being followed while under therapy.

Activity Summary:
Advanced Topics in PAH is designed to delve more deeply into advanced topics related to the management of patients with PAH.

This educational lecture, presented by Dr. Ronald Oudiz, discusses cutting-edge research in PAH and provides case-based discussions on the importance of monitoring patients to determine when and how to optimally alter their PAH therapy.

Activity Summary:
The 6th World Symposium for Pulmonary Hypertension (WSPH) held in Nice, France, summarized scientific advances, re-examined the current guidelines, reviewed the definitions, and debated future directions for PAH.

This educational lecture, presented by Dr. Franz Rischard, discusses the pivotal findings from this important international meeting including new definitions, potential genetic mutations underlying the development of PAH, new diagnostic and treatment algorithm insights, and risk assessment tools to monitor patient status and treatment response.

Activity Summary:
The webcast archive series includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension. These presentations are developed and presented by key expert physicians and further reviewed and approved by the planning committee.